ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022 MAIN-CAV: Phase III Randomized Trial of Maintenance Cabozantinib and Avelumab vs. Avelumab After 1L Platinum-Based Chemo in Pts With mUC (Alliance A032001)
By
ASCO 2022 Conference Coverage
FEATURING
Shilpa Gupta
By
ASCO 2022 Conference Coverage
FEATURING
Shilpa Gupta
722 views
June 14, 2022
Comments 0
Login to view comments.
Click here to Login
GU